Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BALCHEM CORP Director's Dealing 2022

Feb 17, 2022

31041_dirs_2022-02-17_be5d057f-e973-4ca3-8d59-da373a00b9e3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2022-02-10

Reporting Person: Sestrick Michael Robert (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4233 Direct
Common Stock 1780 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (right to buy) $76.89 2027-04-18 Common Stock (3900) Direct
Employee Stock Option (right to buy) $74.57 2028-02-15 Common Stock (3500) Direct
Employee Stock Option (right to buy) $84.09 2029-02-13 Common Stock (3700) Direct
Employee Stock Option (right to buy) $111.94 2030-02-13 Common Stock (3100) Direct
Employee Stock Option (right to buy) $119.13 2031-02-11 Common Stock (2200) Direct
Employee Stock Option (right to buy) $138.07 2032-02-10 Common Stock (1900) Direct

Footnotes

F1: Ownership consists of 416 shares held in Reporting Person's Company 401(k)/profit sharing plan account and 3,817 shares held directly

F2: Ownership of restricted stock vests in Reporting Person 3 years following the grant dates and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

F3: Options vest 20% year 1; 40% year 2; and 40% year 3